Skip to main content

Functional Target Validation for Alzheimer's Disease-Related Dementias

Agency: National Institutes of Health

Assistance Listings
  • 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders

Forecasted opportunityLast Updated: May 13, 2026

Important dates

  • Forecasted post date: May 5, 2026
  • Forecasted application due date: November 6, 2026
  • Forecasted award date: June 14, 2027
  • Forecasted project start date: July 1, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $1,800,000
  • Expected awards: 2

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:RFA-NS-26-034
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: March 11, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting ambitious research projects that propose comprehensive functional validation of newly identified therapeutic target candidates for Alzheimer’s Disease–Related Dementias (ADRD). A major barrier to the development of effective treatments for ADRD, as well as other complex central nervous system disorders, is the lack of well-validated targets that are clearly linked to disease mechanisms. Successful translation of basic discoveries into the clinic depends on the rigor of target validation and confidence in a causal relationship between modulation of a target and its functional physiological consequences relevant to treating or preventing disease. This initiative aims to de-risk subsequent translational research and accelerate the development of novel therapeutic strategies.

NINDS believes that this initiative would be most appropriately supported by a phased award mechanism (for example, R61/R33).  In the initial phase, support would be provided for the development of customized technologies, models, and protocols to modulate the expression or activity of candidate targets and to assess their physiological consequences in relevant in vitro and in vivo disease models. Upon successful achievement of predefined, milestone-based technical feasibility and proof-of-concept criteria, projects would transition to the second phase focused on measuring and cross-validating the effects of target modulation across multiple experimental modalities and collaborating laboratories, in accordance with NIH rigor and reproducibility guidelines.

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop responsive projects and establish appropriate cross-disciplinary collaborations.

Eligibility

Nonprofit

  • Other Native American tribal organizations
  • Nonprofits non-higher education without 501(c)(3)
  • Nonprofits non-higher education with 501(c)(3)

Government

  • State governments
  • City or township governments
  • Federally recognized Native American tribal governments
  • Public and Indian housing authorities
  • County governments
  • Special district governments

Education

  • Independent school districts
  • Public and state institutions of higher education
  • Private institutions of higher education

Miscellaneous

  • Other

Business

  • Small businesses
  • For-profit organizations other than small businesses

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions) are not allowed

Documents

No documents are currently available.

Agency contact information

Email: NINDSDTRADRD@mail.nih.gov

NINDSDTRADRD@mail.nih.gov

NINDS DTR ADRD Please contact via e-mail

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov